نتایج جستجو برای: fih

تعداد نتایج: 235  

2016
Mun Chiang Chan Nicholas E. Ilott Johannes Schödel David Sims Anthony Tumber Kerstin Lippl David R. Mole Christopher W. Pugh Peter J. Ratcliffe Chris P. Ponting Christopher J. Schofield

The hypoxia-inducible factor (HIF) system orchestrates cellular responses to hypoxia in animals. HIF is an α/β-heterodimeric transcription factor that regulates the expression of hundreds of genes in a tissue context-dependent manner. The major hypoxia-sensing component of the HIF system involves oxygen-dependent catalysis by the HIF hydroxylases; in humans there are three HIF prolyl hydroxylas...

Journal: :Journal of cell science 2015
Sarah Karttunen Michael Duffield Nathan R Scrimgeour Lauren Squires Wai Li Lim Mark L Dallas Jason L Scragg Johana Chicher Keyur A Dave Murray L Whitelaw Chris Peers Jeffrey J Gorman Jonathan M Gleadle Grigori Y Rychkov Daniel J Peet

Factor inhibiting HIF (FIH, also known as HIF1AN) is an oxygen-dependent asparaginyl hydroxylase that regulates the hypoxia-inducible factors (HIFs). Several proteins containing ankyrin repeat domains (ARDs) have been characterised as substrates of FIH, although there is little evidence for a functional consequence of hydroxylation on these substrates. This study demonstrates that the transient...

Journal: :Biochemical Society transactions 2004
D E Lancaster M A McDonough C J Schofield

FIH (Factor inhibiting hypoxia-inducible factor), an asparaginyl beta-hydroxylase belonging to the super-family of 2-oxoglutarate and Fe(II)-dependent dioxygenases, catalyses hydroxylation of Asn-803 of hypoxia-inducible factor, a transcription factor that regulates the mammalian hypoxic response. Only one other asparaginyl beta-hydroxylase, which catalyses hydroxylation of both aspartyl and as...

Journal: :Molecular cancer therapeutics 2008
Shan Hua Li Dong Hoon Shin Yang-Sook Chun Myung Kyu Lee Myung-Suk Kim Jong-Wan Park

Hypoxia-inducible factor (HIF)-1 plays a key role in tumor promotion by inducing approximately 60 genes required for tumor adaptation to hypoxia; thus, it is viewed as a target for cancer therapy. For this reason, YC-1, which down-regulates HIF-1alpha and HIF-2alpha at the post-translational level, is being developed as a novel anticancer drug. We here found that YC-1 acts in a novel manner to ...

Journal: :Acta biochimica et biophysica Sinica 2008
Daiyan Fu Aiguo Dai Ruicheng Hu Yunrong Chen Liming Zhu

Hypoxia-inducible factor-1alpha subunit (HIF-1alpha) plays a pivotal role during the development of hypoxia-induced pulmonary hypertension (HPH) by transactivating it' target genes. As an oxygen-sensitive attenuator, factor inhibiting HIF-1 (FIH) hydroxylates a conserved asparagine residue within the C-terminal transactivation domain of HIF-1alpha under normoxia and moderate hypoxia. FIH protei...

2016
Hoon Young Suh Carl C Peck Kyung-Sang Yu Howard Lee

A systematic review was performed to evaluate how the maximum recommended starting dose (MRSD) was determined in first-in-human (FIH) studies with monoclonal antibodies (mAbs). Factors associated with the choice of each MRSD determination method were also identified. PubMed was searched for FIH studies with mAbs published in English between January 1, 1990 and December 31, 2013, and the followi...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2008
Xiaofeng Zheng Sarah Linke José M Dias Xiaowei Zheng Katarina Gradin Tristan P Wallis Brett R Hamilton Maria Gustafsson Jorge L Ruas Sarah Wilkins Rebecca L Bilton Kerstin Brismar Murray L Whitelaw Teresa Pereira Jeffrey J Gorman Johan Ericson Daniel J Peet Urban Lendahl Lorenz Poellinger

Cells adapt to hypoxia by a cellular response, where hypoxia-inducible factor 1alpha (HIF-1alpha) becomes stabilized and directly activates transcription of downstream genes. In addition to this "canonical" response, certain aspects of the pathway require integration with Notch signaling, i.e., HIF-1alpha can interact with the Notch intracellular domain (ICD) to augment the Notch downstream res...

2011
Andrew Melvin Sharon Mudie Sonia Rocha

The hypoxia-inducible factor (HIF) is a master regulator of the cellular response to hypoxia. Its levels and activity are controlled by dioxygenases called prolyl-hydroxylases and factor inhibiting HIF (FIH). To activate genes, HIF has to access sequences in DNA that are integrated in chromatin. It is known that the chromatin-remodeling complex switch/sucrose nonfermentable (SWI/SNF) is essenti...

Journal: :Current oncology 2016
P Satalkar B S Elger D M Shaw

BACKGROUND Participant selection for first-in-human (fih) trials involves complex decisions. The trial design makes it unlikely that participants will receive clinically relevant therapeutic benefit, but they are likely to experience risks of various magnitudes and types. The aim of the present paper was to describe and discuss the views of investigators and ethics committee members about the c...

Journal: :The Journal of biological chemistry 2004
Peppi Koivunen Maija Hirsilä Volkmar Günzler Kari I Kivirikko Johanna Myllyharju

The activity of hypoxia-inducible transcription factor HIF, an alphabeta heterodimer that has an essential role in adaptation to low oxygen availability, is regulated by two oxygen-dependent hydroxylation events. Hydroxylation of specific proline residues by HIF prolyl 4-hydroxylases targets the HIF-alpha subunit for proteasomal destruction, whereas hydroxylation of an asparagine in the C-termi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید